Cardiorespiratory Fitness in Children and Adolescents After Cancer Treatment.
Recruiting
Phase 2
Phase 3
Interventional Study
All Types of Pediatric Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 7 – 23
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 56 (estimated)
- Sponsor
- Universität Duisburg-Essen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The POWER-study is a two-arm exercise intervention study for pediatric patients following acute cancer treatment. This clinical trial will investigate the effects of a 12-week moderate to high-intensity exercise program on cardiorespiratory fitness in children and adolescents beginning 6 weeks after completion of acute cancer treatment.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Children and adolescents between 7 and 23 years of age
* Completion of acute cancer treatment and receiving follow-up care in Krefeld (Helios Hospital Krefeld)
* 6 weeks post cancer-treatment
* Signed informed consent (Parents and Patient)
Exclusion Criteria:
* \<7 years of …
Contacts